INSP logo

Inspire Medical Systems Inc. (INSP)

$67.45

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on INSP

Market cap

$1.95B

EPS

4.53

P/E ratio

15

Price to sales

2.19

Dividend yield

--

Beta

0.731461

Price on INSP

Previous close

$68.20

Today's open

$67.13

Day's range

$66.50 - $68.37

52 week range

$38.91 - $147.03

Profile about INSP

CEO

Timothy P. Herbert

Employees

1246

Headquarters

Golden Valley, MN

Exchange

New York Stock Exchange

Shares outstanding

28910375

Issue type

Common Stock

INSP industries and sectors

Healthcare

Medical Equipment & Supplies

News on INSP

Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026

MINNEAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2026 after the close of trading on Monday, November 2. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

news source

GlobeNewsWire • Oct 5, 2026

news preview

Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation

INSP gains new Category I CPT codes for Inspire V procedures, creating a dedicated coding framework effective Jan. 1, 2028.

news source

Zacks Investment Research • Oct 5, 2026

news preview

Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel

MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that the American Medical Association (AMA) CPT® Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT®) codes that accurately describe and include the Inspire V system. The new Category I codes are scheduled to take effect on January 1, 2028.

news source

GlobeNewsWire • Oct 1, 2026

news preview

Here's Why You Should Retain INSP Stock in Your Portfolio for Now

Inspire Medical is navigating a major product transition as clinical evidence, patient access efforts and reimbursement progress support growth prospects.

news source

Zacks Investment Research • Sep 23, 2026

news preview

Zacks Industry Outlook Medical Systems, American Well and Butterfly Network

Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.

news source

Zacks Investment Research • Sep 14, 2026

news preview

3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk

INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.

news source

Zacks Investment Research • Sep 11, 2026

news preview

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

As of Sept. 10, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

news source

Benzinga • Sep 10, 2026

news preview

Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?

Inspire (INSP) reported earnings 30 days ago. What's next for the stock?

news source

Zacks Investment Research • Sep 2, 2026

news preview

Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.

news source

GlobeNewsWire • Aug 26, 2026

news preview

INSP Stock Rallies Nearly 40% YTD: Can Its Growth Story Continue?

Inspire Medical stock's 39.7% three-month surge is driven by the easing of reimbursement pressures, increasing Inspire V adoption and Project Horizon targeting longer-term expansion.

news source

Zacks Investment Research • Aug 21, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Inspire Medical Systems Inc.

Open an M1 investment account to buy and sell Inspire Medical Systems Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in INSP on M1